SCHEMBL16410850

SCHEMBL16410850

NN1CCC2(CC1)Nc1ccccc1N=C2N=NC1(c2ccccc2Cl)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410652 0.88 PDE7A (0.38) —
SCHEMBL16410715 0.85 — —
SCHEMBL16410761 0.75 ACAT2 (0.40) —
SCHEMBL16410649 0.71 ACAT2 (0.31) —
SCHEMBL16410602 0.69 ACAT2 (0.43) —
SCHEMBL16410770 0.68 ACAT2 (0.44) —
SCHEMBL16410712 0.67 ACAT2 (0.38) —
SCHEMBL16410759 0.65 ACAT2 (0.57) —
SCHEMBL16410634 0.65 CXCR4 (0.34) —
SCHEMBL16410654 0.65 TSHR (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback